220 related articles for article (PubMed ID: 20421439)
1. Use of amplified fragment length polymorphism to identify 42 Cladophialophora strains related to cerebral phaeohyphomycosis with in vitro antifungal susceptibility.
Badali H; de Hoog GS; Curfs-Breuker I; Klaassen CH; Meis JF
J Clin Microbiol; 2010 Jul; 48(7):2350-6. PubMed ID: 20421439
[TBL] [Abstract][Full Text] [Related]
2. [Cladophilaphora bantiana brain abscess treated with voriconazole in an immunocompetent patient].
Atalay MA; Koç AN; Koyuncu S; Ulu Kiliç A; Kurtsoy A; Alp Meşe E
Mikrobiyol Bul; 2014 Jul; 48(3):501-6. PubMed ID: 25052118
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.
Najafzadeh MJ; Badali H; Illnait-Zaragozi MT; De Hoog GS; Meis JF
Antimicrob Agents Chemother; 2010 Apr; 54(4):1636-8. PubMed ID: 20086140
[TBL] [Abstract][Full Text] [Related]
4.
Samaddar A; Mendonsa JM; Sudhaharan S; S N; Kindo AJ; Shetty A; Pamidimukkala U
Microbiol Spectr; 2024 Jun; ():e0078124. PubMed ID: 38920376
[TBL] [Abstract][Full Text] [Related]
5. Antifungal therapy of experimental cerebral phaeohyphomycosis due to Cladophialophora bantiana.
Al-Abdely HM; Najvar LK; Bocanegra R; Graybill JR
Antimicrob Agents Chemother; 2005 May; 49(5):1701-7. PubMed ID: 15855484
[TBL] [Abstract][Full Text] [Related]
6. Veronaea botryosa: molecular identification with amplified fragment length polymorphism (AFLP) and in vitro antifungal susceptibility.
Badali H; Yazdanparast SA; Bonifaz A; Mousavi B; de Hoog GS; Klaassen CH; Meis JF
Mycopathologia; 2013 Jun; 175(5-6):505-13. PubMed ID: 23463524
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of nine antifungal agents against a global collection of Hortaea werneckii isolates, the agent of tinea nigra.
Badali H; Al-Hatmi AMS; Fakhim H; Moghaddasi A; Khodavaisy S; Vaezi A; Ahangarkani F; de Hoog GS; Meis JF
Int J Antimicrob Agents; 2019 Jul; 54(1):95-98. PubMed ID: 31071468
[TBL] [Abstract][Full Text] [Related]
8. Cerebral phaeohyphomycosis due to Cladophialophora bantiana.
Lakshmi V; Padmasri C; Umabala P; Sundaram C; Panigrahi M
Indian J Med Microbiol; 2008; 26(4):392-5. PubMed ID: 18974502
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of eight antifungal drugs against Chaetomiaceae.
Dolatabadi S; Najafzadeh MJ; Houbraken J; Vicente V; de Hoog S; Meis JF
Med Mycol; 2021 Dec; 60(1):. PubMed ID: 34791380
[TBL] [Abstract][Full Text] [Related]
10. Cerebral phaeohyphomycosis due to Cladophialophora bantiana in a French Guianese child.
Miossec C; Jacob S; Peipoch L; Brard M; Jolivet E; Hochedez P; Hamlat A; Desbois N
J Mycol Med; 2020 Apr; 30(1):100918. PubMed ID: 31926829
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of eight antifungal drugs against 104 environmental and clinical isolates of Aureobasidium pullulans.
Najafzadeh MJ; Sutton DA; Keisari MS; Zarrinfar H; de Hoog GS; Chowdhary A; Meis JF
Antimicrob Agents Chemother; 2014 Sep; 58(9):5629-31. PubMed ID: 25001309
[TBL] [Abstract][Full Text] [Related]
12. Phaeohyphomycosis caused by Cladophialophora bantiana.
Martínez-Lamas L; Álvarez M; Llovo J; Gené J; Cano J
Rev Iberoam Micol; 2014; 31(3):203-6. PubMed ID: 23727472
[TBL] [Abstract][Full Text] [Related]
13. In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.
Badali H; Khodavaisy S; Fakhim H; de Hoog GS; Meis JF; Chowdhary A
Antimicrob Agents Chemother; 2015 Dec; 59(12):7818-22. PubMed ID: 26369976
[TBL] [Abstract][Full Text] [Related]
14. An updated comprehensive systematic review of Cladophialophora bantiana and analysis of epidemiology, clinical characteristics, and outcome of cerebral cases.
Kantarcioglu AS; Guarro J; De Hoog S; Apaydin H; Kiraz N
Med Mycol; 2017 Aug; 55(6):579-604. PubMed ID: 28007938
[TBL] [Abstract][Full Text] [Related]
15. Fatal cerebral abscess caused by Cladophialophora bantiana.
George IA; Mathews MS; Karthik R; John L; Sundar A; Abraham OC; Joseph V
J Assoc Physicians India; 2008 Jun; 56():470-2. PubMed ID: 18822631
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of antifungal drugs against Cladophialophora species associated with human chromoblastomycosis.
Vitale RG; Perez-Blanco M; De Hoog GS
Med Mycol; 2009 Feb; 47(1):35-40. PubMed ID: 19115138
[TBL] [Abstract][Full Text] [Related]
17. A case of multiple cerebral abscesses due to infection with Cladophialophora bantiana.
Roche M; Redmond RM; O'Neill S; Smyth E
J Infect; 2005 Dec; 51(5):e285-8. PubMed ID: 15908005
[TBL] [Abstract][Full Text] [Related]
18. Microdilution in vitro antifungal susceptibility of Exophiala dermatitidis, a systemic opportunist.
Badali H; de Hoog GS; Sudhadham M; Meis JF
Med Mycol; 2011 Nov; 49(8):819-24. PubMed ID: 21612562
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
Shi JY; Xu YC; Shi Y; Lü HX; Liu Y; Zhao WS; Chen DM; Xi LY; Zhou X; Wang H; Guo LN
Chin Med J (Engl); 2010 Oct; 123(19):2706-9. PubMed ID: 21034656
[TBL] [Abstract][Full Text] [Related]
20. Cerebral phaeohyphomycosis due to Cladophialophora bantiana: case report and systematic review of cases.
Ganesan V; Hallur V; Velvizhi S; Rajendran T
Infection; 2024 Apr; 52(2):313-321. PubMed ID: 37979132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
